We also performed the same experiments with peripheral whole blood cultures from these donors. Our results indicated considerable intra-and inter-individual variability and substantial differences between the RC of isolated mononuclear cells and whole blood from the same donor. Furthermore, the RC of unstimulated blood did not differ significantly from the repair capacity of stimulated blood but also showed considerable inter-individual variability. Altogether, our results suggest that there is still need for standardisation and validation of this assay before it can be reliably used in human biomonitoring studies.
Introduction
The comet assay is mainly used as a genotoxicity test for the measurement of DNA damage in single cells. However, various modifications of the comet assay have been established for measuring DNA repair (for review, see) (1) (2) (3) . The easiest approach is exposing cells to a specific DNA-damaging agent and measuring remaining damage at intervals after treatment as an indication of the kinetics of repair of this type of damage. More specific information can be obtained by the inclusion of a lesion-specific endonuclease to specifically monitor the presence and removal of different types of DNA base damages such as oxidised or alkylated bases, which are removed by base excision repair (BER), or UVC-induced lesions, which are repaired by nucleotide excision repair (NER) (3) . An alternative approach is to measure the in vitro DNA repair capacity of a cellular extract on a substrate of cellular DNA (agarose-embedded nucleoids) containing specific lesions. In this case, the type of induced DNA damage defines the repair pathway studied. Originally, specific oxidative base damage was induced and the incision activity of the 8-oxoG DNA glycosylase in the extract of lymphocytes was measured (4) . This assay was modified to measure NER, with a substrate (nucleoids from A549 cells) containing bulky adducts induced by benzo[a]pyrene diol epoxide (BPDE) (5) . This modification of the comet assay was able to assess inter-individual differences in NER capacity of protein extracts from lymphocytes with high reproducibility.
NER activity has also been measured using DNA repair inhibitors such as aphidicolin (APC), which lead to an accumulation of repair incisions (e.g. in cells exposed to BPDE). The rate of accumulation of breaks measured by the comet assay should reflect the cells' capacity for NER (6) (7) (8) . The use of DNA repair inhibitors has been proposed for human biomonitoring studies to increase the sensitivity of the comet assay (8) (9) (10) . More recently, based on this approach, an APC-block NER assay was developed to measure NER of damage induced by treatment of lymphocytes with BPDE (11) . Individual repair capacity (RC) was defined as the amount of DNA damage induced by BPDE in the presence of APC minus the damage induced by BPDE and APC alone. This value should mainly reflect the incision capacity of the NER enzymes. Experiments with an NER-deficient human xeroderma pigmentosum cell line demonstrated the specificity of this approach. Repeat experiments with human lymphocytes from different donors suggested low intra-individual, intra-experimental and inter-assay variations (11) .
Because we have been interested in studying genetic susceptibility and DNA repair capacity (12, 13) , we wanted to establish this cellular phenotype assay for NER. First, we repeated the described experiments using isolated peripheral blood mononuclear cells. We also performed these experiments with peripheral whole blood cultures because whole blood cultures are also commonly used in human biomonitoring. Furthermore, we tried to find out whether differences exist with regard to the RC between stimulated and unstimulated blood cultures.
Materials and methods
Chemicals, blood samples and blood culture BPDE was supplied by BIU (Grosshansdorf, Germany). All other chemicals were purchased from Sigma-Aldrich (Munich, Germany). RPMI 1640 medium and phytohaemagglutinin (PHA) were purchased from Invitrogen (Darmstadt, Germany), gentamicin and fetal calf serum (FCS) from Biochrom (Berlin, Germany).
Heparinised blood samples were obtained by venepuncture from 14 healthy volunteers (5 females and 9 males, aged 25.9 ± 9.7 years). All subjects were non-smokers with no known recent exposure to genotoxic chemicals or radiation. Blood samples from nine donors were used for the experiments shown in Figures 1-3 ; blood samples from the other five donors were used for the experiments shown in Figure 4 . The study was performed in accordance with the approval by the ethical committee of the Ulm University.
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Peripheral blood mononuclear cells were isolated by density gradient centrifugation with Ficoll-Paque (GE Healthcare Bio-Sciences, Uppsala, Sweden) and cultured in RPMI medium supplemented with 16% FCS, 1% PHA and 1% gentamicin (final volume: 5 ml). About 100 000 mononuclear cells were used per sample. For the sake of clarity we are using the terms 'lymphocytes' and 'lymphocyte cultures' for isolated peripheral mononuclear cells. Whole blood cultures were set up by adding 0.5 ml blood to 4.5 ml of complete RPMI medium. Cultures were incubated in a humidified incubator at 37°C and 5% CO 2 .
Treatment of blood cultures
In accordance with the protocol described by Vande Loock et al. (11) , the APCblock NER assay was performed 24 h after PHA stimulation of the cultures. PHA stimulation induces transformation and proliferation of T-lymphocytes. Cells were exposed for 2 h to 0.5 or 2.5 µM BPDE (dissolved in DMSO) in the absence or presence of APC. APC (0.5 µg/ml; dissolved in Hanks' solution) was added to the cultures 30 min before the exposure to BPDE. At the end of the treatment, cultures were centrifuged for 10 min at 200 g and the supernatant was removed. The cell pellet was re-suspended in 150 µl (isolated lymphocytes) or 350 µl (whole blood) medium and immediately used for the comet assay. All samples from one complete experiment were processed in parallel to guarantee identical handling.
For a comparison of the NER activity between stimulated and unstimulated blood, the APC-block NER assay was performed with whole blood of five different blood donors 24 h after PHA stimulation and at the beginning of the cultivation period. Two blood samples were investigated from these donors with a 1-week interval. Two BPDE concentrations (0.5 and 2.5 µM) were tested.
Comet assay
The alkaline comet assay was performed according to our standard protocol (1) . Aliquots of the cell suspension (5 µl from whole blood; 10 µl from isolated lymphocytes) were mixed with 120 µl of low-melting point agarose (0.5% in phosphate-buffered saline) and added to microscope slides (with frosted ends), which had been covered with a bottom layer of 1.5% agarose. Slides were lysed for at least 1 h (pH 10; 4°C) and processed using a time of alkali denaturation of 25 min and electrophoresis (0.86 V/cm) of 25 min at a pH > 13. Images of 50 randomly selected cells stained with ethidium bromide were analysed from each coded slide by image analysis (Comet Assay II and Comet Assay IV, Perceptive Instruments, Haverhill, UK). The mean tail intensity (TI; % tail DNA) and the mean tail moment were evaluated as measures for DNA migration. Tail moment is calculated according to the formula: TM = (tail intensity/total comet intensity) × (tail centre of gravity -peak position). For a better comparison with published data (11) , TI values are shown and TM values are only mentioned in case of discrepancies. The first set of experiments (i.e. the determination of RC in isolated lymphocytes and whole blood of nine subjects) was performed with the image analysis software Comet Assay II. After a complete break-down of the computer during the evaluation of slides from subject No. 10, we had to establish the new version Comet Assay IV, which was then used for the following experiments (shown in Figure 4 ). It should be noted that the new equipment yielded slightly different TI values. All samples were processed and analysed by one researcher to reduce assay variability.
Calculation of NER repair capacity
We prepared six cultures for each experiment: one negative (untreated) control, one treated with APC only, two exposed to BPDE (0.5 and 2.5 µM) only and two cultures treated with APC + BPDE (0.5 and 2.5 µM) in combination. The NER repair capacity (RC) was calculated as described by Vande Loock et al. (11) . The TI values measured for APC-plus BPDE-exposed cultures were diminished by TI for APC treatment alone and TI for BPDE treatment alone:
RC = TI (APC + BPDE) -TI (APC) -TI (BPDE)

Statistical analysis
The experiments for the determination of NER capacity in isolated lymphocytes and whole blood were repeated three times at approximately 1-week intervals. RC from all three experiments was calculated. Based on these three repeat measurements, coefficients of variation (CV = standard deviation/mean value) were determined for each subject under each experimental condition. Using one-way analysis of variance with 'subject' as the single factor, an overall CV was determined for each condition.
A Bland-Altman analysis was performed to show the amount of disagreement between the measures of NER in isolated lymphocytes and whole blood (via the differences) of the same subject. For the differences (lymphocytes -blood) averaged out from the three repeat measurements of a subject, limits of agreement according to Bland and Altman were calculated at both BPDE concentrations. These limits are defined as the mean of the intra-individual differences obtained from the nine donors ± the standard deviation of these differences. Under appropriate conditions, these limits may be interpreted as a range within which about 95% of future differences of this kind are predicted to lie (and about 5% will lie outside).
To analyse the statistical significance of differences measured between isolated lymphocytes and blood or between different BPDE concentrations, the two-tailed Wilcoxon signed-rank test was performed.
Results
In order to re-evaluate the assay variability, three blood samples from 9 donors (5 female and 4 male, aged 28.9 ± 11.1 years) were analysed at 1-week intervals. Lymphocytes were treated with both BPDE concentrations (0.5 and 2.5 µM) 24 h after PHA stimulation of the cultures and RC was determined as proposed by Vande Loock et al. (11) . The results are summarised in Table I. A table with the complete raw data is available as  supplementary Table 1 at Mutagenesis Online. The coefficients of variation for the RC after exposure to 0.5 µM BPDE ranged from 3% to 23.2% yielding 13.9% as an overall CV. After treatment with 2.5 µM BPDE, a CV of 53.1% was measured for one subject (No. 8), whereas the CVs of the others ranged between 3.7% and 36%; the overall CV was 28.8%. Thus, variation within repeat measurements with blood from the same subject, as determined by the CV, was noticeable but scattered widely between the subjects for the two BPDE concentrations tested.
The same experiments were also performed with whole blood and led to a similar degree of variation. These results are summarised in Table II. (A table with the complete raw data  is available as supplementary Table 2 at Mutagenesis Online.) At both concentrations, two (different) subjects revealed CVs above 50%, whereas the others showed CV between 10.8 and 44.2% (overall CV = 35.5% at 0.5 µM BPDE) and between 7.5 and 36% (overall CV = 30.6% at 2.5 µM). Systematic RC differences were found between measurements in lymphocytes and blood at both BPDE concentrations: Mean differences between lymphocytes and blood in TI values were 22.5 at 0.5 µM BPDE, P = 0.0039, and 7.8 at 2.5 µM, P = 0.13. The limits of agreement were obtained as 22.5 ± 2 × 4.7 = [13.2; 31.9] (0. Figure 1A for the low BPDE concentration (0.5 µM) and in Figure 1B for the high BPDE concentration (2.5 µM).
In general, there was good agreement between the two comet assay parameters TI and TM (data not shown). However, for donors 6 and 9, lower RC was measured for lymphocytes than for whole blood at the high BPDE concentration when TI was considered but higher RC for lymphocytes were determined when considering TM. The RC distributions for the two BPDE concentrations tested in lymphocytes and blood are also summarised as box plots in Figure 2 . Figure 3 summarises the DNA effects (mean of the nine blood donors) induced by APC, BPDE and APC + BPDE for both BPDE concentrations in lymphocytes (A) and blood (B). The BPDEinduced effects were more pronounced in isolated lymphocytes than in whole blood. The lower BPDE concentration (0.5 µM) only had a small effect on DNA migration in whole blood (P = 0.02). APC caused an increase in TI of BPDE-treated cultures in comparison with the BPDE treatment alone. A statistically significant increase in DNA migration was measured in lymphocytes and blood for both BPDE concentrations (P < 0.01). Figure 4 compares the RC between stimulated and unstimulated blood cultures exposed to BPDE either 24 h after PHA stimulation or directly at the start of the cultures. Mean values from two independent experiments with blood samples from five subjects (males, 20.6 ± 1.34 years old) are shown. A table with the complete raw data is provided as Supplementary Table 3 at Mutagenesis Online. For the low BPDE concentration, no notable difference was measured between whole blood tested 24 h after stimulation and unstimulated blood tested at the start of the culture. For the higher BPDE concentration (2.5 µM), a somewhat lower RC was measured in stimulated blood than in unstimulated blood. However, none of these differences was statistically significant.
Discussion
Various modifications of the comet assay have been established for studying DNA repair (1,3) . The investigation of NER capacity is of particular interest because NER is mainly removing DNA damage induced by exogenous mutagens. Therefore, NER capacity might be a useful biomarker in human biomonitoring studies and cancer prediction (14) .
Various protocols of the comet assay following the challenge of peripheral blood cells with BPDE have been used to measure genomic instability and NER capacity as a potential biomarker in cancer prediction (14-18). Schabath et al. (15) compared the effect of BPDE on DNA migration between bladder cancer patients and controls. They exposed blood cultures 48 h after PHA stimulation for 24 h to 2 µM BPDE and thus measured the 'net result' of DNA damage and repair under these experimental conditions. Xiong et al. (16) studied potential differences between patients with squamous cell carcinoma of the head and neck and controls by treating blood cultures after 72 h for 5 h with 4 µM BPDE, assuming that the level of strand breaks measured reflects the repair capacity of the cells for BPDE adducts. Orlow et al. (17) studied lung cancer patients and exposed lymphocytes after culture for 72 h to BPDE (0.25 µM) for 1 h and performed the comet assay 24 h later. Residual DNA damage 24 h after exposure to BPDE was taken as a measure for repair. More recently, Slyskova et al. (14, 18) measured NER capacity in healthy individuals and patients with colorectal cancer after a challenge of mononuclear blood cells with BPDE after cultivation for 20 h. Cultures were exposed to BPDE (1 µM) for 30 min and analysed after cultivation in fresh medium for 1, 2 and 4 h. Repair capacity was defined as the difference between the level of SSBs measured immediately after the treatment with BPDE at time 0, and the maximum level of SSBs detected within the postincubation period of 1, 2 or 4 h. It remains unclear whether the different protocols used in these studies are equally suited for measuring NER capacity. However, these challenge assays Fig. 2 . RC distributions measured by the comet assay for isolated lymphocytes and whole blood from nine donors exposed to the two BPDE concentrations 0.5 and 2.5 µM. Boxes range from first quartile to third quartile, line in the box = median, plus sign = mean value. Whiskers range from minimum to maximum. TI, tail intensity.
in general cannot exactly determine the contribution of repair to the observed effects in the comet assay because persisting BPDE adducts may also contribute to the effects by producing strand breaks under the alkaline test conditions. The use of DNA polymerase inhibitors such as APC seems to be a useful approach to increase the specificity of a comet assay-based NER assay by discriminating between repairinduced and damage-induced strand breaks. Vande Loock et al. (11) developed an APC-NER phenotype assay that quantifies the DNA strand breaks after in vitro challenge of mononuclear blood cells with BPDE in the absence and presence of APC. They defined the individual RC as the amount of DNA damage induced by BPDE in the presence of APC minus the damage induced by BPDE and APC alone. This value should mainly reflect the incision capacity of the NER enzymes (11). We followed their protocol to establish this method in our laboratory using the same BPDE concentrations (0.5 and 2.5 µM) and the same treatment protocol with APC. However, we did not change the medium before adding BPDE and exposure was not in serum-free medium but in complete blood culture medium. The presence of APC during BPDE exposure should not be a disadvantage and the presence of serum in the medium should not influence the outcome of the test, because comparative experiments performed by Vande Loock et al. (11) did not reveal a significant effect of the presence of serum on BPDE effects. However, our results cannot be directly compared with those published by Vande Loock et al. (11) because these authors used an internal standard (K562 cells) to exclude interelectrophoresis differences. This conversion of the data alters the original values but it is not clear from the description of the results how the use of this standard influenced the results. Nevertheless, the calculated CVs for the repair capacity were even lower in our approach without internal standard in comparison with the data published by Vande Loock et al. (11) , i.e., 3-23% (compared with 16-26%) after challenging with the low BPDE concentration and 4-53% (compared to 64-91%) after challenging with the high BPDE concentration. Because whole blood is frequently used in human biomonitoring and also DNA repair capacities have been investigated after challenging whole blood (15, 16) , we comparatively investigated isolated lymphocytes and whole blood from the same donors at the same time. Interestingly, the calculated RC was consistently much higher in lymphocytes than in whole blood. The agreement between the measured RC of lymphocytes and blood from the same subject as determined by Bland-Altman analysis was very poor. This means that subjects with relatively high RC in lymphocytes did generally not show relatively high RC in whole blood. It cannot be readily decided whether the measurement of NER capacities is more reliable in lymphocytes than in blood. However, it has to be expected that a study measuring RC in lymphocytes may arrive at quite different conclusion as if this study was performed with whole blood. The CVs for RC of the subjects' blood are higher (between 11 and 61% with 0.5 µM BPDE and between 8 and 56% with 2.5 µM BPDE) than those calculated for lymphocytes (between 3 and 23% with 0.5 µM and between 4 and 53% with 2.5 µM). In agreement with the results obtained for lymphocytes, there is no clear difference between the two BPDE concentrations.
However, the calculated RC also seems to depend on the BPDE concentrations used. The higher BPDE concentration (2.5 µM) may already cause some saturation of DNA migration in the presence of APC and an underestimation of the combined effect. Subtraction of relatively high BPDE effect from the saturated combined effect then leads to an apparently lower capacity at the higher concentrations. Furthermore, variation in the damage induced by BPDE might influence the calculated RC more than the actual repair activity. Although the intra-and inter-individual differences in the effect of APC on BPDEinduced effects appear to be rather small, there is considerable variation in the effect of BPDE-induced DNA migration. Because the reliability of the measurements may be limited by the need to subtract the BPDE-induced effect from the measured value, it might be better to use UVC irradiation instead of BPDE for the investigation of RC. UVC does not induce direct strand breaks and there is no need for subtracting an UV-induced effect. UV-induced DNA damage may be more homogenously distributed because UV is not subject to variation in cellular uptake and distribution. BPDE may be bound to proteins before it reaches the nuclear DNA, which may lead to reduced DNAdamaging effects particularly in whole blood. However, also the use of UVC in combination with APC has been shown to lead to large experimental variation and posed serious doubts on the suitability of this approach for measuring individual DNA repair (19) .
The use of isolated lymphocytes may have the disadvantage that the preparation of lymphocytes may cause oxidative stress and affect cell physiology and repair capacity (20) . Lymphocytes as such may be problematic target cells for repair studies. Several studies indicated that lymphocytes in culture are not a reliable tool for measuring cellular DNA repair (20) . This experience led to the development of an alternative assay that measures the repair capacity of a cell extract prepared from lymphocytes (4, 5) . It should be noted that these in vitro assays for DNA repair also measure the capacity of the cells to carry out the initial incision step of excision repair and do not indicate the accuracy of completed repair (10) . Because accuracy of DNA repair may be the decisive factor for the characterisation of genomic stability and cancer prediction (21), the comet assay-based methods measuring incision need to be carefully validated before being used for risk assessment.
The above-mentioned in vitro assays with lymphocyte extracts measure the repair capacity of unstimulated (G 0 ) lymphocytes and human biomonitoring studies sometimes measure repair in native blood samples (10, 12) . Therefore, we were interested in comparing the NER activity of unstimulated blood and blood cultivated after PHA stimulation for 24 h. Our results seem to indicate a high degree of variability in both approaches and no systematic differences. At the lower BPDE concentration, unstimulated blood from three subjects had a higher NER capacity than cultivated blood while in two other samples it was just the opposite. At the higher BPDE concentration, higher NER capacity was measured in unstimulated blood of all five subjects. It is generally assumed that unstimulated lymphocytes have a less efficient DNA repair because of low nucleotide pools (22) . However, the nucleotide pools mainly affect the excision-break rejoining and not the incision step. Incision-break formation occurs in stimulated and unstimulated human T-lymphocytes and incision-related strand breaks may even be enhanced in unstimulated lymphocytes due to accumulation in the absence of repair synthesis and break rejoining (22, 23) . RC as determined here measures incision-related breaks and not repair synthesis. Higher values in unstimulated blood may not necessarily indicate better repair but may also be due to break accumulation because of inefficient rejoining of breaks. Finally, the treatment protocol with BPDE might be critical for a reliable measurement of repair. It might be favourable to measure RC in stimulated blood cultures before lymphocytes start to replicate in order to avoid an influence of replication on the comet assay effects. Cultivation for 24 h might be too long and shorter times should be comparatively tested. Although studies with proliferating V79 Chinese hamster cells have shown that APC only has a clear effect in the comet assay after long exposure (24) , an influence of replication on the measurement of NER capacity should be excluded.
In summary, our study revealed inter-individual variability but also considerable intra-individual variability in NER capacity as measured by an APC-block-based comet assay with BPDE. The power of this assay to reliably measure inter-individual differences in NER capacity in different human populations still has to be determined. The optimal experimental design with regard to the cell system (isolated lymphocytes vs. whole blood), damage-inducing agent (BPDE vs. UV) and the treatment protocol still needs to be defined. Furthermore, comparative investigations with in vitro assay measuring the repair capacity of cell extracts should be performed to establish the most sensitive, stable and reliable assay for measuring NER capacity.
